Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | CA2 | P00918 | 4/20 | 0.34 |
| ▸ | CA5A | P35218 | 4/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20608413 | 0.94 | ALDH1A1 (0.42) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL20455791 | 0.92 | KMT2A (0.44) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL22443203 | 0.90 | ALDH1A1 (0.46) | KMT2AALDH1A1MEN1LMNAMAPT | |
| Methylamine SCHEMBL27521765 | 0.90 | MEN1 (0.41) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL25329169 | 0.83 | LMNA (0.44) | KMT2AALDH1A1MEN1LMNAMAPT | |
| Acrylamide SCHEMBL27706596 | 0.82 | CYP2C19 (0.40) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL9304228 | 0.80 | ALDH1A1 (0.41) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL9225690 | 0.78 | KMT2A (0.55) | KMT2AALDH1A1MEN1LMNAMAPT | |
| SCHEMBL1128206 | 0.76 | KMT2A (0.53) | KMT2AALDH1A1MEN1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL5512637 | 0.72 | KMT2A (0.49) | KMT2AALDH1A1MEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197607-A1 | NON-PULVERULENT ANTISUN COMPOSITION COMPRISING A POLAR OIL PHASE AND HYDROPHOBIC SILICA AEROGEL PARTICLES | L'OREAL (FR) | 2024-06-20 | — | — | US | disclosed |
| US-20150010601-A1 | Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles | L'OREAL (FR) | 2015-01-08 | — | — | US | disclosed |
| US-6106850-A | LIGHT PROTECTIVE COSMETIC/DERMATOLOGICAL COMPOSITION WITH KETONE SULFONIC ACID COMPOSITION | SOCIETE L'OREAL S.A. (FR) | 2000-08-22 | — | — | US | disclosed |
| US-5776472-A | TOPICAL COSMETIC | SOCIETE L'OREAL S.A. (FR) | 1998-07-07 | — | — | US | disclosed |
| US-5730972-A | MIXTURE OF SACCHARIDE ESTER OF ASCORBIC ACID AND WATER SOLUBLE SULPHONIC COMPOUND | L'OREAL (FR) | 1998-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010601-A1 | Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles | KRT18, CUTA, SMURF1 | KMT2A 4095/4885ALDH1A1 4310/4885MEN1 3328/4885 |
| US-20240197607-A1 | NON-PULVERULENT ANTISUN COMPOSITION COMPRISING A POLAR OIL PHASE AND HYDROPHOBIC SILICA AEROGEL PARTICLES | KRT18, CUTA, SMURF1 | KMT2A 4186/4885ALDH1A1 4264/4885MEN1 3244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.